8-K: LanzaTech Expands Biorefining Platform to Produce Nutritional Protein from CO2, Targeting $1 Trillion Market

LanzaTech is expanding its biorefining platform to include the primary production of commercial-scale nutritional protein directly from CO2, aiming to tap into the $1 trillion alternative protein market.

Summary

• LanzaTech is expanding its biorefining platform to produce LanzaTech Nutritional Protein (LNP) as a primary product, using a new microbe in its gas fermentation process.
• LNP is a microbial protein that is a nutrient-rich alternative to plant and animal-based proteins, addressing food security issues and requiring less land and water than traditional protein sources.
• The company has operated a pilot facility for two years and is now in the engineering design phase for a 0.5 to 1.5 ton per day facility, expected to be operational in 2026.
• LanzaTech plans to have commercial-scale facilities producing over 30,000 metric tons per annum, or greater than 80 metric tons per day, operational by 2028.
• The company is also completing trials and testing in animal feed and pet food, and is undergoing the U.S. FDA's GRAS certification process for human nutrition.
• LanzaTech is collaborating with the U.S. Naval Research Laboratory to explore the biomanufacturing potential of nutritional protein from CO2 extracted from seawater.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with a clear strategy for growth into a large market. The technology is innovative and has potential for significant impact. There are risks, but the overall tone is optimistic.

Positives

• LanzaTech's technology allows for protein production using a fraction of the land and water resources required by traditional methods.
• LNP production is independent of weather extremes, enhancing supply chain security.
• LNP has a complete amino acid profile, is highly digestible, and has no allergenicity.
• The company has a low-risk path to commercial production due to 10 years of R&D and piloting.
• LanzaTech's existing biorefining platform and feedstocks can be leveraged for LNP production.
• LanzaTech has successfully trialed LNP in animal feed, pet food, and human food formulations.
• The company is targeting a large and growing alternative protein market.

Negatives

• The company is still in the early stages of commercializing LNP production.
• The company is dependent on regulatory approvals for the marketing and sale of LNP.
• There are risks associated with scaling and developing the LNP business to the required levels of efficiency.
• The company is subject to fluctuations in the availability and cost of feedstocks and other process inputs.

Risks

• The company's ability to scale and develop the LNP business to the maturity and levels of efficiency required to realize returns is uncertain.
• There are potential timing delays in the advancement of projects to the final investment decision stage or into construction.
• Customer adoption of new technologies and platforms is not guaranteed.
• Fluctuations in the availability and cost of feedstocks and other process inputs could impact profitability.
• The availability and continuation of government funding and support is not guaranteed.
• Broader economic conditions, including inflation, interest rates, and supply chain disruptions, could impact the business.
• Unforeseen technical, regulatory, or commercial challenges in scaling proprietary technologies could arise.

Future Outlook

LanzaTech plans to commercialize LNP production, targeting the alternative protein market with pre-commercial facilities operational by 2026 and commercial-scale facilities by 2028. The company aims to produce large quantities of protein without straining land and water resources.

Management Comments

• By coupling a new microbial production strain with our existing bioreactor technology, and our years of operating experience, we have developed a path to mass produce protein from CO2, said Dr. Jennifer Holmgren, CEO of LanzaTech.
• We are excited to collaborate with LanzaTech on this groundbreaking extension of their carbon recycling platform, said Dr. Matthew Yates, Research Biologist at the U.S. Naval Research Laboratory.

Industry Context

This announcement positions LanzaTech as a key player in the growing alternative protein market, leveraging its existing biorefining technology to produce a sustainable and cost-competitive protein source. This aligns with the broader industry trend of seeking sustainable and environmentally friendly alternatives to traditional protein production.

Comparison to Industry Standards

• LanzaTech's approach to producing protein from CO2 is unique compared to traditional plant and animal-based protein production methods.
• The company's technology requires significantly less land and water than traditional agriculture, which is a key differentiator.
• Other companies in the alternative protein space, such as Beyond Meat and Impossible Foods, focus on plant-based proteins, while LanzaTech is using a microbial fermentation process.
• Compared to other gas fermentation companies, LanzaTech has a significant advantage with its 1,450+ patents and existing commercial operations.
• The company's partnership with the U.S. Naval Research Laboratory is a unique collaboration that could lead to new applications for its technology.

Stakeholder Impact

• Shareholders may benefit from the company's expansion into the alternative protein market.
• Employees may see new opportunities as the company grows.
• Customers will have access to a new sustainable protein source.
• Suppliers may see increased demand for feedstocks.
• Creditors may see increased confidence in the company's future prospects.

Next Steps

• LanzaTech will continue to develop its pre-commercial facility, targeting an in-service date in 2026.
• The company will progress with the engineering design for its first commercial-scale facility, targeting an in-service date in 2028.
• LanzaTech will complete trials and testing in animal feed and pet food.
• The company will continue the U.S. FDA's GRAS certification process for LNP's use in human nutrition.
• LanzaTech will evaluate potential sites for the first pre-commercial facilities in collaboration with several partners.

Key Dates

Keywords

LanzaTech Nutritional Protein, LNP, alternative protein, gas fermentation, biorefining, CO2, sustainable protein, nutritional protein, carbon recycling, food security